Atlas Trials

Clinical Trial for Patients With a Stage IV Childhood Renal Tumor, Comparing Upfront Vincristine, Actinomycin-D and Doxorubicin (Standard Arm) With Upfront Vincristine, Carboplatin and Etoposide (Experimental Arm)

Clinical trial NCT03669783 · RECRUITING

Trial details

NCT number
NCT03669783
Sponsor
Assistance Publique Hopitaux De Marseille
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Childhood Renal Tumor
Start date
2023-02-03
Primary completion
2028-10-03
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.